Clinical Trial Update: Neural Progenitor Cell and Paracrine Factors to Treat Hypoxic Ischemic Encephalopathy [NA]

View source ↗

Summary

A clinical trial investigating neural progenitor cells and paracrine factors as a therapy for Hypoxic-Ischemic Encephalopathy; trial status is currently unknown…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoxic-ischemic Encephalopathy

Drugs mentioned

• Neural Progenitor Cells (neural progenitor cells)
• Paracrine Factors (paracrine factors)

Snippet

Sponsor: Navy General Hospital, Beijing | Conditions: Hypoxic-Ischemic Encephalopathy | NA | Status: UNKNOWN